An European Organisation for Research and Treatment of Cancer phase I study of lapatinib and docetaxel as neoadjuvant treatment for Human Epidermal Growth Factor Receptor 2 (HER2) positive locally-advanced/inflammatory or large operable breast cancer
Nom du journal : Eur J Cancer
Année : 2013
Volume : 49
Page de départ : 281
Page de fin : 289